1. Home
  2. IMNN vs SCKT Comparison

IMNN vs SCKT Comparison

Compare IMNN & SCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • SCKT
  • Stock Information
  • Founded
  • IMNN 1982
  • SCKT 1992
  • Country
  • IMNN United States
  • SCKT United States
  • Employees
  • IMNN N/A
  • SCKT N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • SCKT Computer Manufacturing
  • Sector
  • IMNN Health Care
  • SCKT Technology
  • Exchange
  • IMNN Nasdaq
  • SCKT Nasdaq
  • Market Cap
  • IMNN 12.1M
  • SCKT 9.8M
  • IPO Year
  • IMNN 1985
  • SCKT 1995
  • Fundamental
  • Price
  • IMNN $5.75
  • SCKT $1.02
  • Analyst Decision
  • IMNN Buy
  • SCKT
  • Analyst Count
  • IMNN 2
  • SCKT 0
  • Target Price
  • IMNN $182.61
  • SCKT N/A
  • AVG Volume (30 Days)
  • IMNN 55.7K
  • SCKT 12.0K
  • Earning Date
  • IMNN 11-06-2025
  • SCKT 10-23-2025
  • Dividend Yield
  • IMNN N/A
  • SCKT N/A
  • EPS Growth
  • IMNN N/A
  • SCKT N/A
  • EPS
  • IMNN N/A
  • SCKT N/A
  • Revenue
  • IMNN N/A
  • SCKT $16,710,984.00
  • Revenue This Year
  • IMNN N/A
  • SCKT $8.62
  • Revenue Next Year
  • IMNN N/A
  • SCKT N/A
  • P/E Ratio
  • IMNN N/A
  • SCKT N/A
  • Revenue Growth
  • IMNN N/A
  • SCKT N/A
  • 52 Week Low
  • IMNN $4.83
  • SCKT $0.85
  • 52 Week High
  • IMNN $41.22
  • SCKT $1.72
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 36.86
  • SCKT 43.22
  • Support Level
  • IMNN $5.53
  • SCKT $1.01
  • Resistance Level
  • IMNN $5.89
  • SCKT $1.09
  • Average True Range (ATR)
  • IMNN 0.32
  • SCKT 0.04
  • MACD
  • IMNN 0.07
  • SCKT 0.00
  • Stochastic Oscillator
  • IMNN 23.81
  • SCKT 15.00

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.

Share on Social Networks: